Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification.
Yuan J, Shen L, Liu TS, Xu H, Yang J, Wei J, Jiang H, Deng Y, Pan H, Wang Y, Zhang X, Peng Z, Qi C, Zhang L, Hsu P, Song L, Mu L, Sun Q, Gong J, Lyu C.
Yuan J, et al. Among authors: xu h.
Clin Transl Sci. 2024 Dec;17(12):e70091. doi: 10.1111/cts.70091.
Clin Transl Sci. 2024.
PMID: 39610204
Clinical Trial.